Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Objective: To investigate the contribution of neuroleptic drugs to cognitive decline in dementia. Design: Two year prospective, longitudinal study consisting of interviews every four months, with necropsy follow up. Setting: Community settings in Oxfordshire. Subjects: 71 subjects with dementia, initially living at home with informant. Main outcome measures: Cognitive function (score from expanded minimental state examination); behavioural problems (physical aggression, hallucinations, persecutory ideas, and disturbance of diurnal rhythm); and postmortem neuropathological assessment (cortical Lewy body pathology). Results: The mean (SE) decline in cognitive score in the 16 patients who took neuroleptics was twice that in the patients who did not (20.7 (2.9) v 9.3 (1.3), P=0.002). An increased rate of decline was also associated with aggression, disturbed diurnal rhythm, and persecutory ideas. However, only use of neuroleptics and severity of persecutory ideas were independently associated with more rapid cognitive decline when all other variables were adjusted for. The start of neuroleptic treatment coincided with more rapid cognitive decline: median rate of decline was 5 (interquartile range 8.5) points per year before treatment and 11 (12) points per year after treatment (P=0.02). Cortical Lewy body pathology did not account for association between neuroleptic use and more rapid decline. Conclusions: Neuroleptic drugs that are sometimes used to treat behavioural complications of dementia may worsen already poor cognitive function. Randomised controlled trials are needed to confirm a causal relation. Key messages: Neuroleptic drugs are used to treat behavioural problems in patients with dementia, but they may cause more rapid decline in cognitive function In our longitudinal study of patients with dementia we found that the rate of cognitive decline in patients taking neuroleptics was twice that in those not taking neuroleptics Furthermore, the start of neuroleptic treatment was associated with an increase in the rate of cognitive decline Cortical Lewy body pathology at necropsy did not account for the association between neuroleptic use and more rapid decline Although our study does not prove a causal relation, we suggest that there should be regular review of the need for patients to continue taking neuroleptic drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Human Memory and the Cholinergic System: A Relationship to Aging?
Drachman, D. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320001001 · Cited by 1,397
Psychotropic Drug Use and the Risk of Hip Fracture
Ray, W. A., Griffin, M. R., Schaffner, W., Baugh, D. K., & Melton, L. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160702 · Cited by 1,000
Kutteh, W. H. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70610-5 · Cited by 803
The General Household Survey 1974
Hope, K., & O., H. M. S. (1978) · The British Journal of Sociology · doi:10.2307/589665 · Cited by 670
A Metaanalysis of Controlled Trials of Neuroleptic Treatment in Dementia
Schneider, L. S., Pollock, V. E., & Lyness, S. A. (1990) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1990.tb02407.x · Cited by 650
Neuroleptic sensitivity in patients with senile dementia of Lewy body type.
McKeith, I., Fairbairn, A., Perry, R., Thompson, P., & Perry, E. (1992) · BMJ · doi:10.1136/bmj.305.6855.673 · Cited by 624
Self-administration of a questionnaire on chest pain and intermittent claudication.
Rose, G., McCartney, P., & Reid, D. D. (1977) · Journal of Epidemiology & Community Health · doi:10.1136/jech.31.1.42 · Cited by 585
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1430 · Cited by 556
Heterogeneity in dementia of the Alzheimer type: Evidence of subgroups
Mayeux, R., Stern, Y., & Spanton, S. (1985) · Neurology · doi:10.1212/wnl.35.4.453 · Cited by 508
Cited by
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671
“Moreover, both conventional antipsychotic use and the presence of psychotic symptoms have been associated with more rapid cognitive decline in patients with dementia.(13-18)”
BackgroundSchneider, L. S., Dagerman, K., & Insel, P. S. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000200589.01396.6d · Cited by 903
Atypical antipsychotics for aggression and psychosis in Alzheimer's disease
Ballard, C. G., Waite, J., & Birks, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003476.pub2 · Cited by 525
Drug-Induced Cognitive Impairment in the Elderly
Moore, A. R., & O??Keeffe, S. T. (1999) · Drugs & Aging · doi:10.2165/00002512-199915010-00002 · Cited by 409
Ballard, C. G., O'Brien, J. T., Reichelt, K., & Perry, E. K. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0703 · Cited by 396
Ballard, C., Margallo-Lana, M., Juszczak, E., Douglas, S., Swann, A., Thomas, A., O'Brien, J., Everratt, A., Sadler, S., Maddison, C., et al. (2005) · BMJ · doi:10.1136/bmj.38369.459988.8f · Cited by 315
Self-citationNeuroleptic drugs in dementia: benefits and harm
Ballard, C., & Howard, R. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1926 · Cited by 308
Non-pharmacological interventions in dementia
Douglas, S., James, I., & Ballard, C. (2004) · Advances in Psychiatric Treatment · doi:10.1192/apt.10.3.171 · Cited by 296
The Rate of Cognitive Decline in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. P., Perry, R., Wentzel-Larsen, T., Lolk, A., & Kragh-Sørensen, P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.12.1906 · Cited by 283
Wu, Y.-H., & Swaab, D. F. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.11.010 · Cited by 279
Kales, H. C., Valenstein, M., Kim, H. M., McCarthy, J. F., Ganoczy, D., Cunningham, F., & Blow, F. C. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06101710 · Cited by 258
“While it is possible that mortality results from the underlying causes of neuropsychiatric symptoms of dementia, as opposed to a direct medication effect, antipsychotic use has been found to be associated with increased cognitive decline independent of dementia severity and type of behavioral disturbance (33).”
BackgroundCholinesterase inhibitor treatment alters the natural history of Alzheimer's disease
Lopez, O. L. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.3.310 · Cited by 255
Ehrt, U., Broich, K., Larsen, J. P., Ballard, C., & Aarsland, D. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.186239 · Cited by 254
Drug-Induced Cognition Disorders in the Elderly: Incidence, Prevention and Management
Gray, S. L., Lai, K. V., & Larson, E. B. (1999) · Drug Safety · doi:10.2165/00002018-199921020-00004 · Cited by 190
Bright light therapy for agitation in dementia: a randomized controlled trial
Burns, A., Allen, H., Tomenson, B., Duignan, D., & Byrne, J. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209008886 · Cited by 171
“, 2005) and a detrimental effect on cognition (McShane et al., 1997).”
BackgroundManagement of Neuropsychiatric Symptoms in People with Dementia
Ballard, C., & Corbett, A. (2010) · CNS Drugs · doi:10.2165/11319240-000000000-00000 · Cited by 147
“In a cohort study, McShane et al.([60]) reported that typical antipsychotic-treated patients experienced twice the rate of cognitive decline as those not receiving these drugs.”
ResultMental health correlates of aggression in nursing home residents with dementia
Talerico, K. A., Evans, L. K., & Strumpf, N. E. (2002) · The Gerontologist · doi:10.1093/geront/42.2.169 · Cited by 116
“…of these drugs include falls, hip fractures (Thapa, Gideon, & Ray, 1995), tardive dyskinesia and other extrapyramidal symptoms (Woerner, Alvir, Kane, Saltz, & Lieberman, 1995), anticholinergic delirium (Steele, Lucas, & Tune, 1986), sedation, and cognitive decline (McShane et al., 1997).”
BackgroundAggressive behaviour by people with dementia in residential care settings: a review
PULSFORD, D., & DUXBURY, J. (2006) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/j.1365-2850.2006.00964.x · Cited by 61
Metadata
- Authors
- McShane, R., Keene, J., Gedling, K., Fairburn, C., Jacoby, R., & Hope, T.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1997-01-25
- Volume
- 314
- Issue
- 7076
- Pages
- 266
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2030016379
- Cited by
- 267
- References
- 72
- FWCI
- 12.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.